Toll interacting protein (TOLLIP) gene polymorphisms in patients with systemic sclerosis (SSc) associated interstitial lung disease (ILD): association with outcome and survival

被引：0
|
作者：
Schroeder, Niels [1 ]
Andrae, Jitka [1 ]
Knuth-Rehr, Diana [2 ]
Leja, Silke [2 ]
Hunzelmann, Nicolas [2 ]
Boerner, Eda [1 ]
Bonella, Francesco [1 ]
机构：
[1] Univ Duisburg Essen, Pneumonol Dept, Ctr Interstitial & Rare Lung Dis, Ruhrlandklin, Essen, Germany
[2] Univ Hosp Cologne, Dept Dermatol & Venereol, Cologne, Germany
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA4261
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Safety and tolerability of pirfenidone (PFD) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD)-The LOTUSS study
    Khanna, Dinesh
    Albera, Carlo
    Fischer, Aryeh
    Seibold, James
    Raghu, Ganesh
    Khalidi, Nader
    Chung, Lorinda
    Schiopu, Elena
    Chen, Dan
    Gorina, Eduard
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [32] LONG-TERM OUTCOME OF A TARGETED TREATMENT REGIMEN WITH IV CYCLOPHOSPHAMIDE (CYC) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) AND INTERSTITIAL LUNG DISEASE (ILD)
    Ottewell, Lesley
    Walker, Karen
    Griffiths, Bridget
    RHEUMATOLOGY, 2009, 48 : I76 - I76
  • [33] ULTRASOUND LUNG COMETS (ULC) MAY HELP THE SCREENING OF INTERSTITIAL LUNG DISEASE (ILD) IN SYSTEMIC SCLEROSIS (SSC)
    Barskova, T.
    Gargani, L.
    Picano, E.
    Guiducci, S.
    Cerinic, M. Matucci
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 188 - 188
  • [34] COMPARISON OF THE EFFICACY AND SAFETY OF CYCLOPHOSPHAMIDE (SP) AND RITUXIMAB (RTM) IN PATIENTS WITH SYSTEMIC SCLEROSIS (SSC) WITH INTERSTITIAL LUNG DISEASE (ILD)
    Koneva, O.
    Ananieva, L.
    Garzanova, L.
    Desinova, O.
    Ovsyannikova, O.
    Starovoytova, M.
    CHEST, 2020, 157 (06) : 373A - 373A
  • [35] Functional Follow-Up Of Diffuse Interstitial Lung Disease (ild) In Phenotypes Of Systemic Sclerosis (ssc)
    Mateos-Toledo, H.
    Sarmiento-Padilla, G.
    Mejia, M.
    Castillo-Pedroza, J.
    Buendia-Roldan, I.
    Estrada, A.
    Vargas-Dominguez, C.
    Rojas-Serrano, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [36] Assessment of disease progression in systemic sclerosis-associated interstitial lung disease (SSc-ILD) patients using Functional Respiratory Imaging (FRI)
    Clukers, Johan
    Homer, Kate
    Lanclus, Maarten
    Belmans, Dennis
    Van Holsbeke, Cedric
    De Backer, Wifried
    De Backer, Jan W.
    Khanna, Dinesh
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [37] NOCEBO EFFECT ON DIARRHOEA REPORTED IN THE SENSCIS TRIAL OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD)
    Distler, O.
    Highland, K.
    Azuma, A.
    Miede, C.
    Alves, M.
    Sfikakis, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1457 - 1457
  • [38] Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) and Organ Damage: Data from the SENSCIS Trial
    Pope, Janet
    Proudman, Susanna
    Stevens, Wendy
    Henes, Joerg
    Simonovska, Rozeta
    Alves, Margarida
    Allanore, Yannick
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3025 - 3027
  • [39] Continued Treatment with Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD): Interim Analysis of SENSCIS-ON
    Glaeser, S.
    Allanore, Y.
    Vonk, M. C.
    Azuma, A.
    Mayes, M. D.
    Gahlemann, M.
    James, A.
    Kohlbrenner, V
    Stowasser, S.
    Highland, K. B.
    PNEUMOLOGIE, 2021, 75 : S26 - S27
  • [40] Examining Clinical Characteristics of Patients with Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD) and Myositis Antibodies: A Retrospective Case Series
    Pandya, K.
    Raddawi, M.
    D'Silva, K. M.
    Montesi, S. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
12345